THE WHOLE SOY STORY
THE DARK SIDE OF AMERICA'S FAVORITE HEALTH FOOD
By Kaayla T. Daniel

ENDNOTES

NOTE TO READERS: For a full discussion of all issues and complete citations see The Whole Soy Story by Kaayla T. Daniel (New Trends, 2004) or visit the website www.wholesoystory.com.

1. Golbitz P. Soyfoods Consumption in the United States and Worldwide: A Statistical Analysis. Soyatech Inc, Bar Harbor, ME.
2. Organisation for Economic Co-operation and Development. Food Consumption Statistics. (Paris, OECD Publications, 1991).
3. Information about soy and agriculture can be found in Nutritional Anthropology (Liss, 1987) edited by Francis Johnston. For the history of miso, soy sauce, tempeh, tofu and other products see William Shurtleff and Akiko Aoyagi's The Book of Miso (Ten Speed Press, 1976) The Book of Tofu (Ballentine, 1979) and The Book of Tempeh (Ten Speed Press, 1979). Information about the history of soy, including modern manufacturing processes can be found in KeShun Liu's Soybeans: Chemistry, Technology and Utilization (Aspen, 1999).
4. Shurtleff, William. Aoyagi, Akiko. The History of Soybean Crushing: Soy Oil and Soybean Meal. From The History of Soybeans and Soyfoods: Past, Present and Future. Unpublished manuscript. Soyfoods Center, Lafayette, CA.
5. Shurtleff, William. Chronology of Soymilk Worldwide: Part I: 220AD to 1949. Special Exhibit, Museum of Soy, 2001, www.soydailyclub.com.
6. Guy RA. The diets of nursing mothers and young children in Peiping. Chinese Med J, 1936, 50, 434-442.
7. Guy RA, Yeh KS. Roasted soybean in infant feeding. Chinese Med J, 1938, 54, 2, 101-110.
8. Guy RA, Yeh KS. Soybean "milk" as a food for young infants. Chinese Med J, 1938, 54, 1, 1-30.
9. Miller HW. Survey of soyfoods in East Asia, Soybean Digest, June 1948, 22-23. Summarized in Shurtleff, William and Aoyagi, Akiko. Bibliography and Sourcebook on Seventh Day Adventists, 1866-1992 (Lafayette, CA. Soyfoods Center), 74.
10. Tso, Ernest, The development of an infant fed eight months on a soybean milk Diet, Chinese J Physiol, 1928, Vol. 2, no. 1, pp. 33-40.
11. Chou, C.Y., Studies on the use of soybean food in infant feeding in China and the development of formula. Unpublished 1983 manuscript in the possession of Bernard Zimmerli at the Federal Office of Health, Berne, Switzerland.
12. Guy.
13. Guy, Yeh. #7
14. Guy, Yeh. #8
15. Toxicologist Michael Fitzpatrick, Ph.D., as quoted by the Soy Information Network Newsletter, March 5, 1996, pp. 6-7.
16. Liu, KeShun. Soybeans: Chemistry, Technology and Utilization (Aspen, 1999). 379-411.
17. Erickson, David R ed. Practical Handbook of Soybean Processing and Utilization (AOCS Press, 1995).
18. Visser A, Thomas A. Review: Soya protein products - their processing, functionality and application aspects. Food Rev Inter, 1987, 3, 1&2, 220, 1-32.
19. Berk, Zeki. Technology of production of edible flours and protein products from soybeans. FAO Bulletin, Food and Agricultural Organization of the United Nations, Rome, 1992, 24.
20. Liu. 425-436.
21. Liu, 386-388
22. Lusas EW, Rhee KC. Soybean protein processing and utilization. In Erickson, 138-146.
23. SCOGS-101. Evaluation of the health aspects of soy protein isolates as food ingredients. 1979. Prepared for Bureau of Foods, US Food and Drug Administration by the Life Sciences Research Office (FASEB).
24. Rackis JJ. Biologically active components. In Smith, Allan K and Circle, Sidney J eds. Soybeans: Chemistry and Technology, Vol 1 (Westport CT, Avi Publishing, 1972).
25. Liener IE, Kakade ML. Protease inhibitors. In Liener IE, ed. Toxic Constituents in Plant Foodstuffs (NY Academic Press, 1980). 7-71.
26. Liener IE. Trypsin inhibitors: Concern for human nutrition or not? J Nutr, 1986, 116, 5, 921.
27. Anderson RL, Wolfe WJ. Composition changes in trypsin inhibitors, phytic acid, saponins and isoflavones related to soybean processing. J Nutr, 1995, 125, 581S-588S.
28. Rackis JJ, Gumbmann MR. Protease inhibitors physiological properties and nutritional significance. In Ory, Robert L ed. Antinutrients and Natural Toxicants in Foods (Food and Nutrition Press, 1981), 203-238.
29. Reddy NR, Sathe SK eds. Food Phytates (CRC Press, 2002).
30. Hurrell RF et al. Soy protein, phytate and iron absorption in humans. Am J Clin Nutr, 1992, 56, 3, 573-578.
31. Lonnerdal B, Bell JG et al. Effects of phytate removal on zinc absorption from soy formula. Am J Clin Nutr, 1988, 48, 5, 1301-1306.
32. Davidsson L, Galan P et al. Iron bioavailability studied in infants: the influence of phytic acid and ascorbic acid in infant formulas based on soy isolate. Pediatr Res, 1994, 36, 6, 816-822.
33. Cook JD, Morck TA. Lynch SR. The inhibitory effects of soy products on non-heme absorption in man. Am J Clin Nutr, 1981, 34, 12, 2622-2629.
34. Shaw N-S, Chin C-J, Pan W-H. A vegetarian diet rich in soybean products compromises iron status in young students. J Nutr, 1995, 125, 212-219.
35. Pusztai, Arpad. Plant Lectins (Cambridge University Press, 1991).
36. Seeman P, Cheng D, Hes GH. Structure of membrane holes in osmotic and saponin hemolysis. J Cell Biol, 1973, 56, 2, 519-527.
37. Massey LK, Palmer RG, Horner HT. Oxalate content of soybean seeds (Glycine max: Leguminosae), soyfoods and other edible legumes. J Agric Food Chem, 2001, 49, 9, 4262-4266.
38. Solomon, Clive. www.vulvarpainfoundation.org/low oxalatetreatment.htm.
39. Suarez FL, Springfield J et al. Gas production in humans ingesting a soybean flour derived from beans naturally low in oligosaccharides Am J Clin Nutr, 1999, 69, 1, 135-139.
40. Visser A, Thomas A. Review: Soya protein products, their processing, functionality and application aspects. Food Rev Inter, 1987, 3, (1&2) 1-32.
41. Anderson, Wolfe.
42. Rackis. Gumbmann.
43. Peace RW, Sarwar G et al. Trypsin inhibitor levels in soy-based infant formulas and commercial soy protein isolates and concentrates. Food Res Int 1992, 25, 137-141.
44. Billings PC, Longnecker MP et al. Protease inhibitor content of human dietary samples. Nutr Cancer, 1990, 14, 2, 85-93.
45. Kennedy AR. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent. Am J Clin Nutr, 1998, 68 (suppl), 1406S-1412S.
46. Sidhu GS, Oakenfull DG. A mechanism for the hypocholesterolemic activity of saponins. Br J Nutr, 1986, 7, 55, 643.
47. Rao AV. Sung MK. Saponins as anticarcinogens. J Nutr, 1995, 125, 717S-724S.
48. Doyle R, Keller K. Lectins in diagnostic microbiology. Eur J Clin Microbiol, 1983, 3, 4-9.
49. Shamsuddin AM, Yang GY, Vucenik I. Novel anti-cancer function of IP6: growth inhibition and differentiation of human mammary cancer cell lines in vitro. Anticancer Res, 1996, 16 (6A) 3287-3292.
50. Baten A, Ullah A et al. Inositol-phosphate induced enhancement of natural killer cell activity correlates with tumor suppression. Carcinogenesis, 1989, 10, 9 1595-1598.
51. Jenab M, Thompson LU. Role of phytic acid in cancer and other diseases. In Reddy, Sathe. 225-248.
52. FAO Food Allergies Report of the Technical Consultation of the Food and Agricultural Organization of the United Nations, Rome, November 13-14, 1995.
53. Bousquet J, Bjorksten B et al. Scientific criteria and selection of allergenic foods for labeling. Allergy, 1998, 53 (Suppl 47) 3-21.
54. Keeler, Barbara. A nation of lab rats, Sierra Club Magazine, July/August 2001.
55. Foucard T, Malmheden-Yman I. A study on severe food reactions in Sweden - is soy protein an underestimated cause of food anaphylaxis. Allergy, 1999, 53, 3, 261-265.
56. Letter from Ingrid Malmheden-Yman, Ph.D. Senior Chemist Swedish National Food Administration, Livsmedels Verket to Ministry of Health in New Zealand, May 30, 1997 (released under Official Information Act).
57. Fitzpatrick M. Soy formulas and the effects of isoflavones on the thyroid. NZ Med J, 2000, 113, 1103, 24-26.
58. Doerge DR. Inhibition of thyroid peroxidase by dietary flavonoids. Chem Res Toxicol 1996, 9, 16-23.
59. Divi RL, Chang HC, Doerge DR. Anti-thyroid isoflavones from soybean. Biochem Pharmacol, 1997, 54, 1087-1096.
60. Committee on Toxicology (UK). Draft report of the COT Working Group on Phytoestrogens. 4. Sources and concentrations of phytoestrogens in foods and estimated dietary intake.
61. Jabbar MA, Larrea J, Shaw RA. Abnormal thyroid function test in infants with congenital hypothyroidism: the influence of soy-based formula. J Am Coll Nutr, 1997, 16, 280-282.
62. Fitzpatrick.
63. Irvine CHG, Fitzpatrick MG, Alexander SL. Phytoestrogens in soy-based infant foods: concentrations, daily intake and possible biological effects. Proc Soc Exp Biol Med, 1998, 217, 247-253.
64. Irvine CHG, Fitzpatrick M et al. The potential adverse effects of soybean phytoestrogens in infant feeding. NZ Med J, 1995, 24, 318
65. Sharpe RM et al. Infant feeding with soy formula milk: effects on the testis and on blood testosterone levels in marmoset monkeys during the period of neonatal testicular activity. Hum Repro, 2002, 17, 7, 1692-1703.
66. Whitten PL, Lewis C et al. Potential adverse effects of phytoestrogens. J Nutr, 1995, 125, 771S-776S.
67. Committee on Toxicology (UK). Draft report of the COT Working Group on Phytoestrogens. 5: Absorption, distribution, metabolism and excretion of phytoestrogens
68. Clarkson RB et al. Estrogen soybean isoflavones and chronic disease: risks and benefits Trends, Endocrinol MEtab, 1995, 6, 11-16.
69. Kaldas RS, Hughes CL. Reproductive and general metabolic effects of phytoestrogens in mammals. Repr Toxicol, 1989, 3, 81-89.
70. Irvine, Fitzpatrick, Alexander.
71. Santti R, Makela S et al. Phytoestrogens: potential endocrine disrupters in males. Toxicol Envir Health, 1998, 14, 1-2, 223-237.
72. Frawley LS, Neill JD. Age-related changes in serum levels of gonadotropins and testosterone in infantile male rhesus monkeys. Biol Repro 1979, 20, 1147-1151.
73. Mann DR, Gould KG et al. Blockade of neonatal activation of the pituitary testicular axis: effect on peripubertal lutenizing hormone and testosterone secretion and on testicular development in male monkeys J Clin Endocrinol Metab, 1989, 68, 600-607.
74. Winter JSD, Hughes IA et al. Pituitary-gonadal relations in infancy: patterns of serum gonadal steroid concentrations in man from birth to two years of age. J Clin Endocrinol Metab, 1976, 42, 679-686.
75. Sedimeyer IL, Palmert MR. Delayed puberty: analysis of a large case series from an academic center. J Clin Endocrinol Metab, 2002, 87, 4, 1613-1620.
76. Hutson J, Baker M. Hormonal control of testicular descent and the cause of cryptorchidism. Repr Fert Dev, 1994, 6, 151-156.
77. Sharpe R, Shakkeback N. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet, 1993, 341, 1292-1395.]
78. Auger J, Kunstmann J et al. Decline in semen quality among fertile men in Paris during the past 20 years. NEJM, 1995, 332, 5, 281-285.
79. Richard Sharpe MD, as quoted by Aileen Ballantyne in "Why our Men are Getting Less Fertile," London Times, August 29, 1995.
80. Irvine, Fitzpatrick.
81. Winter, Hughes.
82. Mann, Gould.
83. Giddens, Herman et al. Secondary sexual characteristics and menses in young girls seen in office practice. Study from the Pediatric Research in Office Settings Network, 1997, 99, 4, 505-512.
84. Montague, Peter. Editorial: the obscenity of accelerated child development. Ecologist, 1993, 28, 3, 140-142.
85. Zacharias L, Wurtman RJ. Age at menarche. NEJM, 1969, 280, 16, 868-875. The articles includes results reported in Michaelson N. Studies in physical development of Negroes. IV. Onset of puberty. Am J Phys Anthropol, 1944, 2, 151-166.
86. Fenton CL. Poth M. Precocious pseudopuberty. eMedicine, 2001, 2, 5, www.emedicine.com.
87. Irvine, Fitzpatrick.
88. Strom BL, Schinnar R et al. Exposure to soy-based formula in infancy and endocrinological and reproductive outcomes in young adulthood. JAMA, 2001, 286, 7, 897-814.
89. Goldman LR, Newbold R, Swan S. Exposure to soy-based formula in infancy. Letter to the Editor. JAMA, 2001, 286, 19, 2402-2403.
90. Silva M, Reynolds EC. Fluoride content of infant formulae in Australia. Austr Dent J, 1996, 41, 1, 37-42.
91. Fomon SJ, Ekstrand J. Fluoride intake by infants. J Public Health Dent, 1999, 59, 4, 229-234.
92. Weintraub R, Hans G et al. High aluminum content of infant milk formulas. Arch Dis Child, 1986, 61, 914-916.
93. Koo WWK, Kaplan LA, Krug-Wispe SK. Aluminum contamination of infant formulas. J Parenteral Enterol Nutr, 1988, 12, 170-173.
94. Hawkins NM, Coffee S et al. Potential aluminum toxicity in infants fed special infant formula. J Pediatr Gastroenterol Nutr, 1994, 19, 4, 377-381.
95. Tran TT, Chowanadisai W et al. Effect of high dietary manganese intake of neonatal rats on tissue mineral accumulation, striatal dopamine levels and neurodevelopmental status. Neurotoxicol, 2002, 23, 635-643.
96. Trans TT, Crinella FM et al. Effects of neonatal dietary manganese exposure on brain dopamine levels and neurocognitive function. Neurotoxicol, 2002, 23, 645-651.
97. Stasny D, Voegl RS, Picciano MF. Manganese intake and serum manganese concentration of human milk-fed and formula fed infants. Am J Clin Nutr, 1984, 39, 6, 872-878.
98. Collipp PJ, Chen SY, Maitinsky S. Manganese in infant formulas and learning disability. Ann Nutr Metab, 1983, 27, 488-494.
99. Irvine, Fitzpatrick, Alexander.
100. Franke AA et al. Daidzein and genistein concentrations in human milk after soy consumption. Clin Chem, 1996, 42, 955-964.
101. Setchell KDR et al. Exposure of infants to phyto-oestrogens from soy-based infant formula. Lancet, 1997, 350 (9070) 23-27.
102. Declos KB et al. Effects of dietary genistein exposure during development on male and female DC (Sprague-Dawley) rats. Repro Toxicol 1001, 15, 6, 647-663.
103. North K, Golding J, ALSPAC Study Team. A maternal vegetarian diet in pregnancy is associated with hypospadias. BJU Inter, 2000, 85, 107-113.
104. Apfel RJ, Fischer SM. To Do No Harm: DES and the Dilemmas of Modern Medicine (Yale University Press, 1984).
105. Setchell KDR. Naturally occurring non-steroidal estrogens of dietary origin. In McLachlan John A ed. Estrogens in the Environment (Elsevier, 1985).
106. Baskin, Laurence, ed. Hypospadias and Genital Development (NY Kluwer/Plenum, 2004) 16, 28, 234
107. Bickoff, E.M., et al. "Relative potencies of several estrogen-like compounds found in forages," Agri Food Chem., 1962, 10, 410.
108. Woodhams, David J., Nutritional Deficiencies in Soy Protein-based Infant Formulas, paper presented to the New Zealand Ministry of Health, March 5, 1995.
109. Newbold RR, Banks EP et al. Uterine adenocarcinoma in mice treated prenatally with genistein. Cancer Res, 2001, 61, 4325-4328.
110. Markiewicz L et al. In vitro bioassays of non-steroidal phytoestrogens. J Steroids Biochem Mol Biol, 1993, 45, 5, 399-405.
111. Fallon, Sally. Table: Phytoestrogens in Diets of Infants and Adults. Weston A. Price Foundation. For analysis and citations visit www.westonaprice.org/soy/dangersisoflavones.html
112. Sheehan DM. Isoflavone content of breast milk and soy formulas: benefits and risks (letter). Clin Chem, 1997, 43, 850.

© 2006 Michigan Midwives Association.  All Rights Reserved.
Site design and hosting provided by Starr-Rhapsody Creations.